AstraZeneca Abandons Fish Oil Pill for Bad Cholesterol

January 15, 2020

AstraZeneca Plc will stop testing a fish-oil pill for a form of harmful cholesterol that was in the most advanced and expensive stage of clinical trials.

Related Stories